Identifying resilience proteins in key motor tissues that drive motor and cognitive decline and offset the negative effects of ADRD pathologies within and outside the brain

识别关键运动组织中的弹性蛋白,这些蛋白会导致运动和认知能力下降,并抵消大脑内外 ADRD 病理的负面影响

基本信息

  • 批准号:
    10599328
  • 负责人:
  • 金额:
    $ 147.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-01 至 2027-01-31
  • 项目状态:
    未结题

项目摘要

Movement is a volitional behavior linked to Alzheimer’s disease and related dementias (ADRD). Though many older adults show some degree of Alzheimer’s disease and related pathologies, the extent that these pathologies degrade movement varies. The same amount of Alzheimer’s disease and related pathologies may be related to rapid decline in one adult and little loss in another. An adult who maintains movement or has a slower rate of decline in the presence of Alzheimer’s disease and related pathologies manifests motor resilience. To promote motor resilience, it is crucial to identify risk factors or proteins that offset the negative effects of Alzheimer’s disease and related pathologies. Shared neural substrate underlies motor and cognitive resources that control movement. So, it’s not surprising that cognitive resilience proteins are related to motor resilience. This study will complement our ongoing discovery of resilience using deep omics in “cognitive” brain regions with deep omics in key “motor regions” to identify new genes and proteins that may provide motor and cognitive resilience. This study responds to NOT-AG-20-053. We selected 3 key motor tissues in which to identify motor resilience proteins that may offset the negative effects of pathologies of Alzheimer’s disease and related dementias (ADRD) and degeneration in motor systems. We will then test if some of these proteins also provide cognitive resilience. Compelling data support this study: 1) Alzheimer’s disease pathology in brainstem and spinal cord is related to a higher odds of dementia. 2) Large individual differences in degeneration of spinal motoneurons, nerve and muscle, highlight the need to measure their degeneration to isolate motor resilience. 3) Our systems biology and protein validation approach applied to RNAseq in dorsal lateral prefrontal cortex (DLPFC) identified cognitive resilience genes and proteins in prior work. 4) This approach can succeed in motor tissues as high quality RNAseq data, summarized as co-expression modules, was obtained from 3 key motor tissues (brain [SMA], spinal cord and muscle) from the same decedents. 5) As hypothesized, after isolating motor resilience, we identified proteins in DLPFC that provide resilience for motor or cognitive decline and some that provide resilience for both. Motor resilience manifests as slower motor decline. We will quantify Alzheimer’s disease and related pathologies in brain, brainstem, spinal cord, nerve and muscle to isolate motor resilience i.e., motor decline not explained by Alzheimer’s disease and related pathologies and degeneration. Aim 1 will apply a systems biology approach to transcriptome data from 3 key motor tissues (brain, spinal cord and muscle) to discover genes that may provide motor resilience. Aim 2 will verify these genes with SRM proteins and validate that these proteins are related to motor decline in an independent sample of adults. Aim 3 will test if motor resilience proteins also provide cognitive resilience and if aggregating multiple proteins into a person-specific index quantifies high and low resilience related to Alzheimer’s disease phenotypes. Aim 4 will test if resilience proteins link risk factors with motor and cognitive decline. Resilience proteins are high value targets for drug discovery to maintain motor and cognitive function despite the presence of untreatable Alzheimer’s disease and related pathologies. These data will also inform on mechanisms underlying motor and cognitive decline and risk factors which provide resilience.
运动是一种意志行为,与阿尔茨海默病和相关痴呆症(ADRD)有关。虽然许多老年人表现出一定程度的阿尔茨海默氏症和相关的病理,但这些病理损害运动的程度各不相同。等量的阿尔茨海默氏症和相关的病理可能与一个成年人的迅速衰退和另一个成年人的轻微衰退有关。在阿尔茨海默病和相关的病理情况下,保持运动或下降速度较慢的成年人表现出运动韧性。为了促进运动韧性,关键是要确定能够抵消阿尔茨海默病和相关病理的负面影响的危险因素或蛋白质。共享的神经底物是控制运动的运动和认知资源的基础。因此,认知韧性蛋白与运动韧性相关也就不足为奇了。这项研究将补充我们正在进行的弹性发现,使用“认知”大脑区域的深层组学和关键“运动区”的深层组学,以确定可能提供运动和认知弹性的新基因和蛋白质。 这项研究回应了NOT-AG-20-053。我们选择了3个关键的运动组织,在其中识别运动弹性蛋白,这些蛋白质可能抵消阿尔茨海默病和相关痴呆(ADRD)和运动系统退化的病理影响。然后,我们将测试其中一些蛋白质是否也提供认知弹性。 令人信服的数据支持这项研究:1)脑干和脊髓中的阿尔茨海默病病理与患痴呆症的几率更高有关。2)脊髓运动神经元、神经和肌肉变性的个体差异很大,突出了测量它们的变性以分离运动弹性的必要性。3)我们的系统生物学和蛋白质验证方法应用于背外侧前额叶皮质(DLPFC)的RNAseq,在以前的工作中发现了认知弹性基因和蛋白质。4)这种方法可以在运动组织中获得成功,因为高质量的RNAseq数据总结为共表达模块,从同一死者的3个关键运动组织(脑[SMA]、脊髓和肌肉)获得。5)如假设的那样,在分离出运动弹性后,我们在DLPFC中发现了为运动或认知衰退提供弹性的蛋白质,以及一些为两者都提供弹性的蛋白质。 运动复原力表现为运动下降较慢。我们将量化阿尔茨海默病和相关的大脑、脑干、脊髓、神经和肌肉的病理,以分离运动韧性,即阿尔茨海默病和相关的病理和退行性疾病无法解释的运动下降。目标1将应用系统生物学方法转录3个关键运动组织(脑、脊髓和肌肉)的基因组数据,以发现可能提供运动弹性的基因。AIM 2将用SRM蛋白验证这些基因,并在一个独立的成人样本中验证这些蛋白与运动性衰退有关。AIM 3将测试运动弹性蛋白是否也提供认知弹性,以及是否将多个蛋白质聚合到一个特定于人的指数中来量化与阿尔茨海默病表型相关的高弹性和低弹性。目标4将测试弹性蛋白是否将风险因素与运动和认知能力下降联系起来。弹性蛋白是药物发现的高价值靶点,可维持运动和认知功能,尽管存在无法治疗的阿尔茨海默病和相关病理。这些数据还将提供有关运动和认知衰退的潜在机制以及提供弹性的风险因素的信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARON S BUCHMAN其他文献

ARON S BUCHMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARON S BUCHMAN', 18)}}的其他基金

Identifying resilience proteins in key motor tissues that drive motor and cognitive decline and offset the negative effects of ADRD pathologies within and outside the brain
识别关键运动组织中的弹性蛋白,这些蛋白会导致运动和认知能力下降,并抵消大脑内外 ADRD 病理的负面影响
  • 批准号:
    10369971
  • 财政年份:
    2022
  • 资助金额:
    $ 147.09万
  • 项目类别:
Thinking about walking: Can digital phenotyping of mobility improve the prediction of Alzheimer's dementia and inform on the pathologies and proteins contributing to this association?
思考步行:移动的数字表型可以改善阿尔茨海默氏痴呆症的预测并提供有关导致这种关联的病理学和蛋白质的信息吗?
  • 批准号:
    10524888
  • 财政年份:
    2022
  • 资助金额:
    $ 147.09万
  • 项目类别:
Thinking about walking: Can digital phenotyping of mobility improve the prediction of Alzheimer's dementia and inform on the pathologies and proteins contributing to this association?
思考步行:移动的数字表型可以改善阿尔茨海默氏痴呆症的预测并提供有关导致这种关联的病理学和蛋白质的信息吗?
  • 批准号:
    10710174
  • 财政年份:
    2022
  • 资助金额:
    $ 147.09万
  • 项目类别:
Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults
将睡眠呼吸暂停确定为老年人脑干 ADRD 病理的非认知表型
  • 批准号:
    10378737
  • 财政年份:
    2021
  • 资助金额:
    $ 147.09万
  • 项目类别:
Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults
将睡眠呼吸暂停确定为老年人脑干 ADRD 病理的非认知表型
  • 批准号:
    10602556
  • 财政年份:
    2021
  • 资助金额:
    $ 147.09万
  • 项目类别:
Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults
将睡眠呼吸暂停确定为老年人脑干 ADRD 病理的非认知表型
  • 批准号:
    10178701
  • 财政年份:
    2021
  • 资助金额:
    $ 147.09万
  • 项目类别:
Elucidating the molecular drivers of impaired mobility within and outside the CNS in Alzheimer’s disease and related disorders
阐明阿尔茨海默病及相关疾病中枢神经系统内外活动能力受损的分子驱动因素
  • 批准号:
    10613427
  • 财政年份:
    2019
  • 资助金额:
    $ 147.09万
  • 项目类别:
Elucidating the molecular drivers of impaired mobility within and outside the CNS in Alzheimer’s disease and related disorders
阐明阿尔茨海默病及相关疾病中枢神经系统内外活动能力受损的分子驱动因素
  • 批准号:
    9920077
  • 财政年份:
    2019
  • 资助金额:
    $ 147.09万
  • 项目类别:
Elucidating the molecular drivers of impaired mobility within and outside the CNS in Alzheimer’s disease and related disorders
阐明阿尔茨海默病及相关疾病中枢神经系统内外活动能力受损的分子驱动因素
  • 批准号:
    10374874
  • 财政年份:
    2019
  • 资助金额:
    $ 147.09万
  • 项目类别:
Impaired Gait in Older Adults: Pathologies of Alzheimer's disease and Related Disorders
老年人步态受损:阿尔茨海默病及相关疾病的病理学
  • 批准号:
    9889016
  • 财政年份:
    2017
  • 资助金额:
    $ 147.09万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 147.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 147.09万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 147.09万
  • 项目类别:
    Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 147.09万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 147.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 147.09万
  • 项目类别:
    Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 147.09万
  • 项目类别:
    Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 147.09万
  • 项目类别:
    Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
  • 批准号:
    498278
  • 财政年份:
    2024
  • 资助金额:
    $ 147.09万
  • 项目类别:
    Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
  • 批准号:
    24K04938
  • 财政年份:
    2024
  • 资助金额:
    $ 147.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了